Moreover, in support of such a switch in breast cancer driver, from ERα to HOXA1, Mahajan et al. have shown that HOXA1 expression in breast cancer can be induced by ERα and that this could be linked to the acquisition of Tamoxifen resistance. Here, ESR1 is linked to breast carcinoma.